Cargando…
Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
Hodgkin Lymphoma (HL) is a malignancy that frequently affects young adults. Although, there are effective treatments not every patient responds, necessitating the development of novel therapeutic approaches, especially for relapsed and refractory cases. The two TNF receptor family members CD30 and C...
Autores principales: | Rajendran, Sakthi, Li, Yating, Ngoh, Evelyn, Wong, Hiu Yi, Cheng, Man Si, Wang, Cheng-I, Schwarz, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768943/ https://www.ncbi.nlm.nih.gov/pubmed/31616638 http://dx.doi.org/10.3389/fonc.2019.00945 |
Ejemplares similares
-
Ectopic CD137 expression facilitates the escape of Hodgkin and Reed-Sternberg cells from immunosurveillance
por: Pang, Wan Lu, et al.
Publicado: (2013) -
CD20 Over-Expression in Hodgkin-Reed-Sternberg Cells of Classical Hodgkin Lymphoma: the Neglected Quest
por: Benharroch, Daniel, et al.
Publicado: (2015) -
Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
por: Parente, Paola, et al.
Publicado: (2020) -
CD30 induces Reed‐Sternberg cell‐like morphology and chromosomal instability in classic Hodgkin lymphoma cell lines
por: Watanabe, Mariko, et al.
Publicado: (2023) -
New molecular targets in Hodgkin and Reed-Sternberg cells
por: Sadaf, Hummaira, et al.
Publicado: (2023)